Brief: Lifecore Biomedical Reports Financial Results
BRIEF-Lifecore Biomedical Reports Financial Results Aug 5 (Reuters) - Lifecore Biomedical, Inc. LFCR.O:
LIFECORE BIOMEDICAL REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2026, AND PROVIDES CORPORATE UPDATE
LIFECORE BIOMEDICAL, - Q2 2026 REVENUES $34.20 MILLION, DOWN 6.2% FROM PRIOR YEAR
LIFECORE BIOMEDICAL, - REAFFIRMS REVENUE AND ADJUSTED EBITDA GUIDANCE FOR CALENDAR YEAR 2026
Source text: ID:nGNX4ljklg
Further company coverage: LFCR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lifecore Biomedical
See all newsNASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:40 AM
Lifecore Biomedical, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Lifecore Biomedical Reports Financial Results
Lifecore Biomedical Inc expected to post a loss of 22 cents a share - Earnings Preview